Trials / Recruiting
RecruitingNCT06512181
Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study for the conservative management of placenta accreta spectrum disorders (PAS), which are a major cause of maternal morbidity and mortality. The most common management strategy for PAS in the United States is a preterm cesarean-hysterectomy. However, accumulating data show that conservative management is safer and is preferred by some patients. In selected participants (n=15) who desire uterine preservation, the investigators provide the option of conservative management, which will be defined as leaving the placenta in the uterus after delivery of the infant. This is a single-arm single-site pilot study where all participants will be carefully monitored during a standard postpartum inpatient stay and with outpatient follow-up until the uterus is empty.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Conservative/Expectant Management | At time of caesarean section, participants will not have a hysterectomy, but will be treated clinically to preserve their uterus. |
Timeline
- Start date
- 2025-04-21
- Primary completion
- 2030-09-01
- Completion
- 2030-12-31
- First posted
- 2024-07-22
- Last updated
- 2025-04-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06512181. Inclusion in this directory is not an endorsement.